|
|
|
Welcome to MyelomaLinks,
your monthly source of myeloma news,
research updates, clinical trials
and events of The Leukemia & Lymphoma
Society (LLS). For even more information,
regularly visit our Patient
Services and Disease
Information Web
sections. | |
 |
 |
Latest
Myeloma
News
Ginger
Provides Significant Reduction of
Chemotherapy-induced Nausea
A large,
randomized clinical trial has shown a
significant reduction of chemotherapy-related
nausea for patients taking ginger supplements
along with standard antiemetic drugs, offering
relief during the first day after chemotherapy
for the more than 73% of patients with cancer
treated with chemotherapy who suffer from this
side
effect. | |
|
 |
LLS
Features
::READ
MORE::
.....................................................................................................................................
Research
Roundup ::READ
MORE::
.....................................................................................................................................
IRC Question of
the Month
:: READ
MORE::
| |
|
Inspirational
Stories
 Learn
how individuals touched by blood cancer
cope. LLS's LifeMosaic
Web feature offers hundreds of
inspiring stories by patients and families. Read
them or submit
your own.
|
Here to
Help
Visit the LLS
Web site www.LLS.org regularly for even more information.
Many of our education programs are archived free
of charge for convenient access 24/7.
If
you haven't found what you're looking for in
MyelomaLinks , please call our
Information Resource Center (IRC) to speak with
trained information specialists. IRC staff are
available Monday through Friday, 9 a.m. to 6
p.m. ET, toll free at (800) 955-4572; email
infocenter@lls.org; or click the "Live Patient Help" button
on the www.LLS.org homepage.
Please consider
a tax-deductible gift to LLS. Donate
online today and help us make
a difference in the lives of patients and their
families.
|
Help for Patients with a Difficult Blood
Cancer
The Leukemia & Lymphoma Society
offers Co-Pay Assistance for Myeloma
Patients.
:: READ
MORE:: |
| |
|
|
Commentary
Deborah Banker, Ph.D., reports
on promising new research that was presented
at the recent prestigious American Society of
Clinical Oncology
meeting.
Clinical Trials
We invite you to
use our LLS-supported
TrialCheck® Web site
, a clinical trial search service that
offers patients and caregivers immediate access
to listings of all myeloma clinical trials.
Answer just a few simple questions and a list of
available clinical trials related to your cancer
will appear in an easy-to-read list of search
results.
You may also want to
visit the National Cancer Institute's Cancer
Trials Support Unit, providing resources
and information on Phase III cancer treatment
trials supported by the National Cancer
Institute. ::SELECTED TRIALS::
Newsfeeds &
Podcasts
Now
you can get RSS Feeds and Podcasts from LLS.
:: CLICK HERE TO SIGN
UP::
Free
eNewsletters
Free LLS
eNewsletters deliver the latest information on
research and treatment options, patient services
programs and fundraising events.
::CLICK HERE TO SIGN UP
::
| | | |
| 
| | | |
|
|
|
Anti-DKK1 mAb (BHQ880) as a potential
therapeutic agent for multiple myeloma.
::READ
MORE::
The treatment of
multiple myeloma using vincristine, carmustine,
melphalan, cyclophosphamide, and prednisone
(VBMCP) alternating with high-dose
cyclophosphamide and alpha(2)beta interferon
versus VBMCP: results of a phase III Eastern
Cooperative Oncology Group Study E5A93.
::READ
MORE::
Comparison of
whole-body MR imaging and conventional X-ray
examination in patients with multiple myeloma
and implications for therapy. ::READ
MORE::
Emerging
treatments for multiple myeloma: beyond
immunomodulatory drugs and bortezomib.
::READ
MORE::
Long-term
outcome in relapsed and refractory multiple
myeloma treated with thalidomide. Balancing
efficacy and side-effects. ::READ
MORE::
> Back to the
top | |
Selected
Trials
Phase II: Celgene High Risk Multiple Myeloma
(MM) Revlimid Induction and Maintenance RX
::READ
MORE::
Phase II Study of Thalidomide,
Clarithromycin, Lenalidomide, and Dexamethasone
for Newly Diagnosed Multiple Myeloma
(T-BiRD) ::READ
MORE::
Phase III Study of Vorinostat (MK0683) an
HDAC Inhibitor, or Placebo in Combination with
Bortezomib in Patients With Multiple
Myeloma ::READ
MORE::
Phase II Trial of Romidepsin and Bortezomib
for Multiple Myeloma ::READ
MORE::
A Study of Sativex® for Pain Relief in
Patients with Advanced Malignancy ::READ
MORE::
> Back to the top
| |
IRC Question of
the Month
| 
Q: I
have just started chemotherapy, and I enjoy
going to the beach in the summer. Are there any
precautions I should take?
A: Everyone should reduce
their exposure to the harmful effects of the
sun's ultraviolet (UV) rays because of the risk
of skin cancers. In addition, patients with
myeloma should avoid all direct sun exposure
after completing certain drug and/or radiation
therapy. Treatment often makes the skin more
sensitive to the effects of the sun.
Skin-related side effects of treatment may
include dryness, redness, itchiness or lesions.
These may occur during and after drug or
radiation therapy. Patients should check with
their treatment teams about specific sun-related
effects of their therapy. They may be related to
treatment, to the disease itself or to
complications such as infection. If you're
preparing a vacation that may include sun
exposure it is best to get a medical guidance
about appropriate precautions, including topical
solutions (creams, lotions or gel) to protect,
soothe, soften or moisturize skin or to prevent
itching.
Plan outdoor activities for early morning or
late afternoon. Seek natural shade from trees or
other shelter. UV rays are reflected by sand,
water and snow; so take extra care when on a
beach, boating or skiing holiday. Use a
sunscreen with a sun protective factor (SPF) of
15 or higher in general and choose one that
protects against all of the sun's rays. Wear an
SPF 30 sunscreen on any areas directly affected
by treatment with radiation. Sunscreen must be
reapplied after swimming or sweating.
If you lose your hair because of therapy,
protect your head from sun exposure and
irritation by wearing soft hats or scarves.
Wearing a wide-brimmed hat, long-sleeved shirts
and trousers when in the sun is also suggested.
Try to avoid lightly woven fabrics as they may
allow rays through. New clothing lines have been
developed to protect against UV
rays .
Please call our
Information Resource Center (IRC) to speak with
a trained information specialist. IRC staff are
available Monday through Friday, 9 a.m. to 6
p.m. ET, toll free at (800) 955-4572. Contact
us online or click the "Live
Patient Help" button on the www.LLS.org
homepage.
> Back to the
top | |
| | | |
|
|
 |
Supported by an
unrestricted
educational grant
from
 |
 |
|
Contact Us: The
Leukemia & Lymphoma Society, 1311 Mamaroneck
Ave., White Plains, NY 10605, (800)
955-4572
|
|
| Visit our e-Store
& Special Offers page where you can
support businesses that support
LLS. | | | | | |
|
| | | |
